PubRank

Monica Nordberg

Author PubWeight™ 21.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas. Environ Health Perspect 2011 1.39
2 Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China (ChinaCad). Biometals 2002 1.28
3 Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors. Biochimie 2009 1.15
4 Plasma metallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population. Diabetes Care 2006 1.15
5 Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China. Biometals 2004 1.08
6 Non-renal effects and the risk assessment of environmental cadmium exposure. Environ Health Perspect 2014 1.03
7 Biomonitoring for occupational health risk assessment (BOHRA). Toxicol Lett 2009 0.93
8 Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol 2008 0.91
9 Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China. Toxicol Appl Pharmacol 2006 0.91
10 Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol 2008 0.91
11 Recent developments in quantification methods for metallothionein. J Inorg Biochem 2002 0.89
12 Kidney dysfunction and cadmium exposure--factors influencing dose-response relationships. J Trace Elem Med Biol 2012 0.89
13 Separation of proteins including metallothionein in cerebrospinal fluid by size exclusion HPLC and determination of trace elements by HR-ICP-MS. Brain Res 2007 0.86
14 Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters. Toxicol Sci 2007 0.83
15 Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biol Trace Elem Res 2012 0.82
16 The Declaration of Brescia on Prevention of the Neurotoxicity of Metals Brescia, Italia 17-18 June 2006. Med Lav 2007 0.81
17 The Declaration of Brescia on prevention of the neurotoxicity of metals June 18, 2006. Am J Ind Med 2007 0.81
18 Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure. Exp Biol Med (Maywood) 2009 0.81
19 Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9). Regul Toxicol Pharmacol 2008 0.81
20 Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Exp Biol Med (Maywood) 2012 0.80
21 Relationship between mercury concentration in blood, cognitive performance, and blood pressure, in an elderly urban population. Biometals 2002 0.79
22 Metals in motor neuron diseases. Exp Biol Med (Maywood) 2006 0.78
23 Metallothionein gene expression in peripheral lymphocytes and renal dysfunction in a population environmentally exposed to cadmium. Toxicol Appl Pharmacol 2005 0.78
24 Increased hepatic and decreased urinary metallothionein in rats after cessation of oral cadmium exposure. Basic Clin Pharmacol Toxicol 2009 0.77
25 Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China. Toxicol Sci 2005 0.75
26 The application of metallothionein (MT) gene expression in peripheral blood lymphocytes (PBLs) as a biomarker of cadmium exposure. Biometals 2004 0.75
27 Obituary. Dr. Maths Berlin. Med Lav 2015 0.75